Aromatase inhibitors as adjuvant treatment of breast cancer
Open Access
- 31 January 2006
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 57 (1), 53-61
- https://doi.org/10.1016/j.critrevonc.2005.05.005
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Aromatase Inhibition: Translation into a Successful Therapeutic ApproachClinical Cancer Research, 2005
- Pharmacology of new aromatase inhibitorsThe Breast, 1996
- Postmenopausal estrogen synthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancerJournal of Steroid Biochemistry, 1990
- Mechanisms of Action of Aminoglutethimide as Endocrine Therapy of Breast CancerDrugs, 1988
- 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCERThe Lancet, 1984
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967
- The use of prednisolone in the treatment of disseminated breast carcinomaCancer, 1958
- Bilateral Adrenalectomy in the Treatment of Cancer of the BreastArchives of Surgery, 1955
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896